0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031
Published Date: July 2025
|
Report Code: QYRE-Auto-26L8907
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Recombinant Human Serum Albumin Market Outlook 2022
BUY CHAPTERS

Global Recombinant Human Serum Albumin Market Size, Manufacturers, Supply Chain, Sales Channel and Clients, 2025-2031

Code: QYRE-Auto-26L8907
Report
July 2025
Pages:126
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Recombinant Human Serum Albumin Market Size

In 2024, the global market size of Recombinant Human Serum Albumin was estimated to be worth US$ 85.1 million and is forecast to reach approximately US$ 137 million by 2031 with a CAGR of 7.2% during the forecast period 2025-2031.

Recombinant Human Serum Albumin Market

Recombinant Human Serum Albumin Market

Recombinant Human Serum Albumin (Rec. HSA) is animal origin free expressed in E.coli without animal or human derived raw materials. It is also free from other contaminating serum proteins. Recombinant human serum albumin (rHSA) is genetically engineered and derived from a rice-based expression system. It is a highly purified and completely animal-, virus-, and bacteria-free product that was developed as an alternative to plasma-derived HSA, to which it is structurally equivalent.
Market Drivers
The recombinant human serum albumin (rHSA) market is driven by the growing demand for safer and more reliable alternatives to plasma-derived albumin. Recombinant technology eliminates the risk of contamination from blood-borne pathogens, making rHSA a preferred choice for pharmaceutical and biotechnological applications. Increasing use in drug delivery systems, cell culture media, and vaccine production further boosts demand. Additionally, advancements in biotechnology and the rising prevalence of chronic diseases create a need for efficient therapeutic solutions, positioning rHSA as a critical component in modern medicine.
Market Challenges
Despite its advantages, the rHSA market faces challenges, including high production costs associated with recombinant technology. The complexity of large-scale manufacturing and the need for strict regulatory compliance can hinder market growth. Additionally, limited awareness about rHSA among end-users, particularly in emerging markets, restricts adoption. Competition from traditional plasma-derived albumin, which remains cost-effective for certain applications, poses another significant barrier for widespread adoption of recombinant alternatives.
Industry Trends
Key industry trends include increasing research into cost-effective and scalable production methods, such as plant-based or yeast-expression systems, to enhance accessibility. The integration of rHSA into advanced biopharmaceutical formulations, including targeted drug delivery and regenerative medicine, is expanding its applications. Sustainability and ethical considerations are also driving interest in non-plasma-derived albumin. Moreover, collaborations between biotechnology firms and pharmaceutical companies are accelerating innovation and market penetration, ensuring a robust growth trajectory for the rHSA industry.
Global key players of recombinant human serum albumin (Recombinant Human Serum Albumin) include Albumedix, Merck and Ventria (InVitria). The top three manufacturers account for about 88% of the global share. North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively. North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively. In terms of product type, ScrHSA is the largest segment, holding about 91% share. In terms of application, cell culture media is the largest downstream segment with about 73% share; followed by medical supplements.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Recombinant Human Serum Albumin, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Recombinant Human Serum Albumin.
The Recombinant Human Serum Albumin market size, estimations, and forecasts are provided in terms of sales volume (Kg) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Recombinant Human Serum Albumin market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Recombinant Human Serum Albumin manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and regions.

Scope of Recombinant Human Serum Albumin Market Report

Report Metric Details
Report Name Recombinant Human Serum Albumin Market
Forecasted market size in 2031 approximately US$ 137 million
CAGR 7.2%
Forecasted years 2025 - 2031
Segment by Type
  • OsrHSA
  • ScrHSA
Segment by Application
  • Cell Culture Media
  • Medical Supplements
  • Other
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Sartorius, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type and by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Sales (consumption), revenue of Recombinant Human Serum Albumin in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
  • Chapter 3: Detailed analysis of Recombinant Human Serum Albumin manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Recombinant Human Serum Albumin sales, revenue, price, gross margin, sales by region, by Type, by Application, and recent development, etc.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: North America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 8: APAC by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 9: Europe by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 10: Latin America by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 11: Middle East and Africa by Type, by Application and by country, sales, and revenue for each segment.
  • Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
  • Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 14: Research Findings and Conclusion.

FAQ for this report

What is the Recombinant Human Serum Albumin Market size in 2031?

Ans: The Recombinant Human Serum Albumin Market size in 2031 will be approximately US$ 137 million.

What is the market share of major companies in Recombinant Human Serum Albumin Market?

Ans: The top three manufacturers account for about 88% of the global share.

What is the Recombinant Human Serum Albumin Market production share by region?

Ans: North America is the largest producer of recombinant albumin in the world with about 46% share, followed by Europe and China with 42% and 7% share respectively.

What is the Recombinant Human Serum Albumin Market share by region?

Ans: North America is the largest market with approximately 59% share, followed by Europe and China with approximately 29% and 6% market share, respectively.

What is the Recombinant Human Serum Albumin Market share by type?

Ans: In terms of product type, ScrHSA is the largest segment, holding about 91% share.

Who are the main players in the Recombinant Human Serum Albumin Market report?

Ans: The main players in the Recombinant Human Serum Albumin Market are Sartorius, Merck, Ventria (InVitria), NCPC, Oryzogen, HiMedia

What are the Application segmentation covered in the Recombinant Human Serum Albumin Market report?

Ans: The Applications covered in the Recombinant Human Serum Albumin Market report are Cell Culture Media, Medical Supplements, Other

What are the Type segmentation covered in the Recombinant Human Serum Albumin Market report?

Ans: The Types covered in the Recombinant Human Serum Albumin Market report are OsrHSA, ScrHSA

Recommended Reports

Albumin & Derivatives

Recombinant Human Proteins

Protein Services & Kits

1 Study Coverage
1.1 Recombinant Human Serum Albumin Product Introduction
1.2 Market by Type
1.2.1 Global Recombinant Human Serum Albumin Market Size Growth Rate by Type (2020 VS 2024 VS 2031)
1.2.2 OsrHSA
1.2.3 ScrHSA
1.3 Market by Application
1.3.1 Global Recombinant Human Serum Albumin Market Size Growth Rate by Application (2020 VS 2024 VS 2031)
1.3.2 Cell Culture Media
1.3.3 Medical Supplements
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global Recombinant Human Serum Albumin Market Size Estimates and Forecasts
2.1.1 Global Recombinant Human Serum Albumin Revenue 2020-2031
2.1.2 Global Recombinant Human Serum Albumin Sales 2020-2031
2.2 Recombinant Human Serum Albumin Market Size by Region: 2024 Versus 2031
2.3 Recombinant Human Serum Albumin Sales by Region (2020-2031)
2.3.1 Global Recombinant Human Serum Albumin Sales by Region: 2020-2025
2.3.2 Global Recombinant Human Serum Albumin Sales Forecast by Region (2026-2031)
2.3.3 Global Recombinant Human Serum Albumin Sales Market Share by Region (2020-2031)
2.4 Recombinant Human Serum Albumin Market Estimates and Projections by Region (2026-2031)
2.4.1 Global Recombinant Human Serum Albumin Revenue by Region: 2020-2025
2.4.2 Global Recombinant Human Serum Albumin Revenue Forecast by Region (2026-2031)
2.4.3 Global Recombinant Human Serum Albumin Revenue Market Share by Region (2020-2031)
3 Market Segments
3.1 Breakdown Data by Type
3.1.1 Global Recombinant Human Serum Albumin Sales by Type (2020-2031)
3.1.1.1 Global Recombinant Human Serum Albumin Sales Volume by Type (2020-2031)
3.1.1.2 Global Recombinant Human Serum Albumin Sales Market Share by Type (2020-2031)
3.1.2 Global Recombinant Human Serum Albumin Revenue by Type (2020-2031)
3.1.2.1 Global Recombinant Human Serum Albumin Revenue by Type (2020-2031)
3.1.2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Type (2020-2031)
3.1.3 Recombinant Human Serum Albumin Average Selling Price (ASP) by Type (2020-2031)
3.2 Breakdown Data by Application
3.2.1 Global Recombinant Human Serum Albumin Sales by Application (2020-2031)
3.2.1.1 Global Recombinant Human Serum Albumin Sales Volume by Application (2020-2031)
3.2.1.2 Global Recombinant Human Serum Albumin Sales Market Share by Application (2020-2031)
3.2.2 Global Recombinant Human Serum Albumin Revenue by Application (2020-2031)
3.2.2.1 Global Recombinant Human Serum Albumin Revenue by Application (2020-2031)
3.2.2.2 Global Recombinant Human Serum Albumin Revenue Market Share by Application (2020-2031)
3.2.3 Recombinant Human Serum Albumin Average Selling Price (ASP) by Application (2020-2031)
3.3 by Type and by Application Crossing Analysis
3.3.1 OsrHSA of Recombinant Human Serum Albumin Revenue Market Share by Application
3.3.2 ScrHSA of Recombinant Human Serum Albumin Revenue Market Share by Application
4 Global Recombinant Human Serum Albumin by Manufacturers
4.1 Global Top Recombinant Human Serum Albumin Manufacturers by Sales (2020-2025)
4.1.1 Global Recombinant Human Serum Albumin Sales by Manufacturer (2020-2025)
4.1.2 Global Recombinant Human Serum Albumin Sales Market Share by Manufacturer (2020-2025)
4.2 Global Top Recombinant Human Serum Albumin Manufacturers by Revenue (2020-2025)
4.2.1 Global Recombinant Human Serum Albumin Revenue by Manufacturer (2020-2025)
4.2.2 Global Recombinant Human Serum Albumin Revenue Share by Manufacturer (2020-2025)
4.3 Global Recombinant Human Serum Albumin Price by Manufacturer (2020-2025)
4.4 Competitive Landscape
4.4.1 Key Recombinant Human Serum Albumin Manufacturers Covered: Ranking by Revenue
4.4.2 Global Recombinant Human Serum Albumin Market Concentration Ratio (CR5 and HHI) & (2020-2025)
4.4.3 Global Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.5 Global Recombinant Human Serum Albumin Manufacturing Base Distribution, Product Type
4.5.1 Recombinant Human Serum Albumin Manufacturers Manufacturing Base Distribution, Headquarters
4.5.2 Date of International Manufacturers Enter into Recombinant Human Serum Albumin Market
4.5.3 Manufacturers Recombinant Human Serum Albumin Product Type and Application
4.5.4 OsrHSA Market Sales of Recombinant Human Serum Albumin by Manufacturer
4.5.5 ScrHSA Market Sales of Recombinant Human Serum Albumin by Manufacturer
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
5 Company Profiles
5.1 Sartorius
5.1.1 Sartorius Company Information
5.1.2 Sartorius Description, Business Overview
5.1.3 Sartorius Recombinant Human Serum Albumin Products Offered
5.1.4 Sartorius Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
5.1.5 Sartorius Recombinant Human Serum Albumin Sales by Product in 2024
5.1.6 Sartorius Recombinant Human Serum Albumin Sales by Application in 2024
5.1.7 Sartorius Recombinant Human Serum Albumin Sales by Geographic Area in 2024
5.1.8 Sartorius Recent Developments
5.2 Merck
5.2.1 Merck Company Information
5.2.2 Merck Description, Business Overview
5.2.3 Merck Recombinant Human Serum Albumin Products Offered
5.2.4 Merck Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
5.2.5 Merck Recombinant Human Serum Albumin Sales by Product in 2024
5.2.6 Merck Recombinant Human Serum Albumin Sales by Application in 2024
5.2.7 Merck Recombinant Human Serum Albumin Sales by Geographic Area in 2024
5.2.8 Merck Recent Developments
5.3 Ventria (InVitria)
5.3.1 Ventria (InVitria) Company Information
5.3.2 Ventria (InVitria) Description, Business Overview
5.3.3 Ventria (InVitria) Recombinant Human Serum Albumin Products Offered
5.3.4 Ventria (InVitria) Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
5.3.5 Ventria (InVitria) Recombinant Human Serum Albumin Sales by Product in 2024
5.3.6 Ventria (InVitria) Recombinant Human Serum Albumin Sales by Application in 2024
5.3.7 Ventria (InVitria) Recombinant Human Serum Albumin Sales by Geographic Area in 2024
5.3.8 Ventria (InVitria) Recent Developments
5.4 NCPC
5.4.1 NCPC Company Information
5.4.2 NCPC Description, Business Overview
5.4.3 NCPC Recombinant Human Serum Albumin Products Offered
5.4.4 NCPC Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
5.4.5 NCPC Recombinant Human Serum Albumin Sales by Product in 2024
5.4.6 NCPC Recombinant Human Serum Albumin Sales by Application in 2024
5.4.7 NCPC Recombinant Human Serum Albumin Sales by Geographic Area in 2024
5.4.8 NCPC Recent Developments
5.5 Oryzogen
5.5.1 Oryzogen Company Information
5.5.2 Oryzogen Description, Business Overview
5.5.3 Oryzogen Recombinant Human Serum Albumin Products Offered
5.5.4 Oryzogen Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
5.5.5 Oryzogen Recombinant Human Serum Albumin Sales by Product in 2024
5.5.6 Oryzogen Recombinant Human Serum Albumin Sales by Application in 2024
5.5.7 Oryzogen Recombinant Human Serum Albumin Sales by Geographic Area in 2024
5.5.8 Oryzogen Recent Developments
5.6 HiMedia
5.6.1 HiMedia Company Information
5.6.2 HiMedia Description, Business Overview
5.6.3 HiMedia Recombinant Human Serum Albumin Products Offered
5.6.4 HiMedia Recombinant Human Serum Albumin Sales, Revenue and Gross Margin (2020-2025)
5.6.5 HiMedia Recombinant Human Serum Albumin Sales by Product in 2024
5.6.6 HiMedia Recombinant Human Serum Albumin Sales by Application in 2024
5.6.7 HiMedia Recombinant Human Serum Albumin Sales by Geographic Area in 2024
5.6.8 HiMedia Recent Developments
6 North America
6.1 North America Recombinant Human Serum Albumin Market Size YoY Growth 2020-2031
6.2 North America Recombinant Human Serum Albumin Market Facts & Figures by Country
6.2.1 North America Recombinant Human Serum Albumin Sales by Country (2020-2031)
6.2.2 North America Recombinant Human Serum Albumin Revenue by Country (2020-2031)
6.3 North America Recombinant Human Serum Albumin Sales by Type (2020-2025)
6.4 North America Recombinant Human Serum Albumin Sales by Application (2020-2025)
7 Asia-Pacific
7.1 Asia-Pacific Recombinant Human Serum Albumin Market Size YoY Growth 2020-2031
7.2 Asia-Pacific Recombinant Human Serum Albumin Market Facts & Figures by Region
7.2.1 Asia-Pacific Recombinant Human Serum Albumin Sales by Region (2020-2031)
7.2.2 Asia-Pacific Recombinant Human Serum Albumin Revenue by Region (2020-2031)
7.3 Asia-Pacific Recombinant Human Serum Albumin Sales by Type (2020-2025)
7.4 Asia-Pacific Recombinant Human Serum Albumin Sales by Application (2020-2025)
8 Europe
8.1 Europe Recombinant Human Serum Albumin Market Size YoY Growth 2020-2031
8.2 Europe Recombinant Human Serum Albumin Market Facts & Figures by Country
8.2.1 Europe Recombinant Human Serum Albumin Sales by Country (2020-2031)
8.2.2 Europe Recombinant Human Serum Albumin Revenue by Country (2020-2031)
8.3 Europe Recombinant Human Serum Albumin Sales by Type (2020-2025)
8.4 Europe Recombinant Human Serum Albumin Sales by Application (2020-2025)
9 Latin America
9.1 Latin America Recombinant Human Serum Albumin Market Size YoY Growth 2020-2031
9.2 Latin America Recombinant Human Serum Albumin Market Facts & Figures by Country
9.2.1 Latin America Recombinant Human Serum Albumin Sales by Country (2020-2031)
9.2.2 Latin America Recombinant Human Serum Albumin Revenue by Country (2020-2031)
9.3 Latin America Recombinant Human Serum Albumin Sales by Type (2020-2025)
9.4 Latin America Recombinant Human Serum Albumin Sales by Application (2020-2025)
10 Middle East and Africa
10.1 Latin America Recombinant Human Serum Albumin Market Size YoY Growth 2020-2031
10.2 Middle East and Africa Recombinant Human Serum Albumin Market Facts & Figures by Country
10.2.1 Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2020-2031)
10.2.2 Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2020-2031)
10.3 Middle East and Africa Recombinant Human Serum Albumin Sales by Type (2020-2025)
10.4 Middle East and Africa Recombinant Human Serum Albumin Sales by Application (2020-2025)
11 Supply Chain and Sales Channel analysis
11.1 Recombinant Human Serum Albumin Supply Chain Analysis
11.2 Recombinant Human Serum Albumin Key Raw Materials and Upstream Suppliers
11.3 Recombinant Human Serum Albumin Clients Analysis
11.4 Recombinant Human Serum Albumin Sales Channel and Sales Model Analysis
11.4.1 Recombinant Human Serum Albumin Distribution Channel Analysis: Indirect Sales VS Direct Sales
11.4.2 Recombinant Human Serum Albumin Distribution Channel Analysis: Online Sales VS Offline Sales
11.4.3 Recombinant Human Serum Albumin Distributors
12 Recombinant Human Serum Albumin Market Dynamics
12.1 Recombinant Human Serum Albumin Industry Trends
12.2 Recombinant Human Serum Albumin Market Drivers
12.3 Recombinant Human Serum Albumin Market Challenges
12.4 Recombinant Human Serum Albumin Market Restraints
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.1.1 Research Programs/Design
14.1.1.2 Market Size Estimation
14.1.1.3 Market Breakdown and Data Triangulation
14.1.2 Data Source
14.1.2.1 Secondary Sources
14.1.2.2 Primary Sources
14.2 Author Details
14.3 Disclaimer
List of Tables
 Table 1. Global Recombinant Human Serum Albumin Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Global Recombinant Human Serum Albumin Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 3. Global Recombinant Human Serum Albumin Market Size by Region (US$ Million): 2024 VS 2031
 Table 4. Global Recombinant Human Serum Albumin Sales by Region (2020-2025) & (Kg)
 Table 5. Global Recombinant Human Serum Albumin Sales Forecast by Region (2026-2031) & (Kg)
 Table 6. Global Recombinant Human Serum Albumin Revenue by Region (2020-2025) & (US$ Million)
 Table 7. Global Recombinant Human Serum Albumin Revenue Forecast by Region (2026-2031) & (US$ Million)
 Table 8. Global Recombinant Human Serum Albumin Sales Volume by Type (2020-2025) & (Kg)
 Table 9. Global Recombinant Human Serum Albumin Sales Volume by Type (2026-2031) & (Kg)
 Table 10. Global Recombinant Human Serum Albumin Revenue by Type (2020-2025) & (US$ Million)
 Table 11. Global Recombinant Human Serum Albumin Revenue Forecast by Type (2026-2031) & (US$ Million)
 Table 12. Global Recombinant Human Serum Albumin Sales Volume by Application (2020-2025) & (Kg)
 Table 13. Global Recombinant Human Serum Albumin Sales Volume by Application (2026-2031) & (Kg)
 Table 14. Global Recombinant Human Serum Albumin Revenue by Application (2020-2025) & (US$ Million)
 Table 15. Global Recombinant Human Serum Albumin Revenue by Application (2026-2031) & (US$ Million)
 Table 16. Global Recombinant Human Serum Albumin Sales by Manufacturer (2020-2025) & (Kg)
 Table 17. Global Recombinant Human Serum Albumin Sales Share by Manufacturer (2020-2025)
 Table 18. Recombinant Human Serum Albumin Revenue by Manufacturer (2020-2025) & (US$ Million)
 Table 19. Recombinant Human Serum Albumin Revenue Share by Manufacturer (2020-2025)
 Table 20. Key Manufacturers Recombinant Human Serum Albumin Price (2020-2025) & (US$/g)
 Table 21. Ranking of Global Top Recombinant Human Serum Albumin Manufacturers by Revenue (US$ Million) in 2024
 Table 22. Global Recombinant Human Serum Albumin Manufacturers Market Concentration Ratio (CR5 and HHI) & (2020-2025)
 Table 23. Global Recombinant Human Serum Albumin by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Human Serum Albumin as of 2024)
 Table 24. Recombinant Human Serum Albumin Manufacturers Manufacturing Base Distribution and Headquarters
 Table 25. Date of International Manufacturers Enter into Recombinant Human Serum Albumin Market
 Table 26. Manufacturers Recombinant Human Serum Albumin Product Type and Application
 Table 27. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 28. Sartorius Company Information
 Table 29. Sartorius Description and Business Overview
 Table 30. Sartorius Recombinant Human Serum Albumin Product
 Table 31. Sartorius Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 32. Sartorius Sales Proportion of Recombinant Human Serum Albumin by Product in 2024
 Table 33. Sartorius Sales Proportion of Recombinant Human Serum Albumin by Application in 2024
 Table 34. Sartorius Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2024
 Table 35. Sartorius Recent Developments
 Table 36. Merck Company Information
 Table 37. Merck Description and Business Overview
 Table 38. Merck Recombinant Human Serum Albumin Product
 Table 39. Merck Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 40. Merck Sales Proportion of Recombinant Human Serum Albumin by Product in 2024
 Table 41. Merck Sales Proportion of Recombinant Human Serum Albumin by Application in 2024
 Table 42. Merck Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2024
 Table 43. Merck Recent Developments
 Table 44. Ventria (InVitria) Company Information
 Table 45. Ventria (InVitria) Description and Business Overview
 Table 46. Ventria (InVitria) Recombinant Human Serum Albumin Product
 Table 47. Ventria (InVitria) Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 48. Ventria (InVitria) Sales Proportion of Recombinant Human Serum Albumin by Product in 2024
 Table 49. Ventria (InVitria) Sales Proportion of Recombinant Human Serum Albumin by Application in 2024
 Table 50. Ventria (InVitria) Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2024
 Table 51. Ventria (InVitria) Recent Developments
 Table 52. NCPC Company Information
 Table 53. NCPC Description and Business Overview
 Table 54. NCPC Recombinant Human Serum Albumin Product
 Table 55. NCPC Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 56. NCPC Sales Proportion of Recombinant Human Serum Albumin by Product in 2024
 Table 57. NCPC Sales Proportion of Recombinant Human Serum Albumin by Application in 2024
 Table 58. NCPC Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2024
 Table 59. NCPC Recent Developments
 Table 60. Oryzogen Company Information
 Table 61. Oryzogen Description and Business Overview
 Table 62. Oryzogen Recombinant Human Serum Albumin Product
 Table 63. Oryzogen Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 64. Oryzogen Sales Proportion of Recombinant Human Serum Albumin by Product in 2024
 Table 65. Oryzogen Sales Proportion of Recombinant Human Serum Albumin by Application in 2024
 Table 66. Oryzogen Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2024
 Table 67. Oryzogen Recent Developments
 Table 68. HiMedia Company Information
 Table 69. HiMedia Description and Business Overview
 Table 70. HiMedia Recombinant Human Serum Albumin Product
 Table 71. HiMedia Recombinant Human Serum Albumin Sales (Kg), Revenue (US$ Million), Price (US$/g) and Gross Margin (2020-2025)
 Table 72. HiMedia Sales Proportion of Recombinant Human Serum Albumin by Product in 2024
 Table 73. HiMedia Sales Proportion of Recombinant Human Serum Albumin by Application in 2024
 Table 74. HiMedia Sales Proportion of Recombinant Human Serum Albumin by Geographic Area in 2024
 Table 75. HiMedia Recent Developments
 Table 76. North America Recombinant Human Serum Albumin Sales by Country (2020-2025) & (Kg)
 Table 77. North America Recombinant Human Serum Albumin Sales by Country (2026-2031) & (Kg)
 Table 78. North America Recombinant Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 79. North America Recombinant Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 80. North America Recombinant Human Serum Albumin Sales by Type (2020-2025) & (Kg)
 Table 81. North America Recombinant Human Serum Albumin Sales by Application (2020-2025) & (Kg)
 Table 82. Asia-Pacific Recombinant Human Serum Albumin Sales by Region (2020-2025) & (Kg)
 Table 83. Asia-Pacific Recombinant Human Serum Albumin Sales by Region (2026-2031) & (Kg)
 Table 84. Asia-Pacific Recombinant Human Serum Albumin Revenue by Region (2020-2025) & (US$ Million)
 Table 85. Asia-Pacific Recombinant Human Serum Albumin Revenue by Region (2026-2031) & (US$ Million)
 Table 86. Asia-Pacific Recombinant Human Serum Albumin Sales by Type (2020-2025) & (Kg)
 Table 87. Asia-Pacific Recombinant Human Serum Albumin Sales by Application (2020-2025) & (Kg)
 Table 88. Europe Recombinant Human Serum Albumin Sales by Country (2020-2025) & (Kg)
 Table 89. Europe Recombinant Human Serum Albumin Sales by Country (2026-2031) & (Kg)
 Table 90. Europe Recombinant Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 91. Europe Recombinant Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 92. Europe Recombinant Human Serum Albumin Sales by Type (2020-2025) & (Kg)
 Table 93. Europe Recombinant Human Serum Albumin Sales by Application (2020-2025) & (Kg)
 Table 94. Latin America Recombinant Human Serum Albumin Sales by Country (2020-2025) & (Kg)
 Table 95. Latin America Recombinant Human Serum Albumin Sales by Country (2026-2031) & (Kg)
 Table 96. Latin America Recombinant Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 97. Latin America Recombinant Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 98. Latin America Recombinant Human Serum Albumin Sales by Type (2020-2025) & (Kg)
 Table 99. Latin America Recombinant Human Serum Albumin Sales by Application (2020-2025) & (Kg)
 Table 100. Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2020-2025) & (Kg)
 Table 101. Middle East and Africa Recombinant Human Serum Albumin Sales by Country (2026-2031) & (Kg)
 Table 102. Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2020-2025) & (US$ Million)
 Table 103. Middle East and Africa Recombinant Human Serum Albumin Revenue by Country (2026-2031) & (US$ Million)
 Table 104. Middle East and Africa Recombinant Human Serum Albumin Sales by Type (2020-2025) & (Kg)
 Table 105. Middle East and Africa Recombinant Human Serum Albumin Sales by Application (2020-2025) & (Kg)
 Table 106. Recombinant Human Serum Albumin Key Raw Materials, Industry Status and Trend
 Table 107. Recombinant Human Serum Albumin Key Raw Materials and Upstream Suppliers
 Table 108. Recombinant Human Serum Albumin Clients Status and Trend
 Table 109. Recombinant Human Serum Albumin Typical Clients
 Table 110. Recombinant Human Serum Albumin Distributors
 Table 111. Recombinant Human Serum Albumin Market Trends
 Table 112. Recombinant Human Serum Albumin Market Drivers
 Table 113. Recombinant Human Serum Albumin Market Challenges
 Table 114. Recombinant Human Serum Albumin Market Restraints
 Table 115. Research Programs/Design for This Report
 Table 116. Key Data Information from Secondary Sources
 Table 117. Key Data Information from Primary Sources
 Table 118. QYR Business Unit and Senior & Team Lead Analysts


List of Figures
 Figure 1. Recombinant Human Serum Albumin Product Picture
 Figure 2. Global Recombinant Human Serum Albumin Market Size by Type (US$ Million): 2020 VS 2024 VS 2031
 Figure 3. Global Recombinant Human Serum Albumin Sales Market Share by Type in 2024 & 2031
 Figure 4. OsrHSA Product Picture
 Figure 5. ScrHSA Product Picture
 Figure 6. Global Recombinant Human Serum Albumin Market Size by Application (US$ Million): 2020 VS 2024 VS 2031
 Figure 7. Global Recombinant Human Serum Albumin Sales Market Share by Application in 2024 & 2031
 Figure 8. Cell Culture Media
 Figure 9. Medical Supplements
 Figure 10. Other
 Figure 11. Recombinant Human Serum Albumin Report Years Considered
 Figure 12. Global Recombinant Human Serum Albumin Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Recombinant Human Serum Albumin Market Size 2020-2031 (US$ Million)
 Figure 14. Global Recombinant Human Serum Albumin Sales 2020-2031 (Kg)
 Figure 15. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Region (2020-2031)
 Figure 16. Global Recombinant Human Serum Albumin Revenue Market Share by Region (2020-2031)
 Figure 17. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Type (2020-2031)
 Figure 18. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Type (2020-2031)
 Figure 19. Recombinant Human Serum Albumin Average Selling Price (ASP) by Type (2020-2025) & (US$/g)
 Figure 20. Global Recombinant Human Serum Albumin Sales Market Share Forecast by Application (2020-2031)
 Figure 21. Global Recombinant Human Serum Albumin Revenue Market Share Forecast by Application (2020-2031)
 Figure 22. Recombinant Human Serum Albumin Average Selling Price (ASP) by Application (2020-2025) & (US$/g)
 Figure 23. OsrHSA of Recombinant Human Serum Albumin Revenue Market Share by Application, 2024 VS 2031
 Figure 24. ScrHSA of Recombinant Human Serum Albumin Revenue Market Share by Application, 2024 VS 2031
 Figure 25. Global Recombinant Human Serum Albumin Sales Share by Manufacturer in 2024
 Figure 26. Recombinant Human Serum Albumin Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 27. OsrHSA Market Sales Proportion by Manufacturer in 2024
 Figure 28. ScrHSA Market Sales Proportion by Manufacturer in 2024
 Figure 29. North America Recombinant Human Serum Albumin Revenue 2020-2031 (US$ Million)
 Figure 30. North America Recombinant Human Serum Albumin Sales Market Share by Type (2020-2025)
 Figure 31. North America Recombinant Human Serum Albumin Sales Market Share by Application (2020-2025)
 Figure 32. Asia-Pacific Recombinant Human Serum Albumin Revenue 2020-2031 (US$ Million)
 Figure 33. Asia-Pacific Recombinant Human Serum Albumin Sales Market Share by Region (2020-2031)
 Figure 34. Asia-Pacific Recombinant Human Serum Albumin Revenue Market Share by Region (2020-2031)
 Figure 35. Asia-Pacific Recombinant Human Serum Albumin Sales Market Share by Type (2020-2025)
 Figure 36. Asia-Pacific Recombinant Human Serum Albumin Sales Market Share by Application (2020-2025)
 Figure 37. Europe Recombinant Human Serum Albumin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 38. Europe Recombinant Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 39. Europe Recombinant Human Serum Albumin Revenue Market Share by Country (2020-2031)
 Figure 40. Europe Recombinant Human Serum Albumin Sales Market Share by Type (2020-2025)
 Figure 41. Europe Recombinant Human Serum Albumin Sales Market Share by Application (2020-2025)
 Figure 42. Latin America Recombinant Human Serum Albumin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 43. Latin America Recombinant Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Recombinant Human Serum Albumin Revenue Market Share by Country (2020-2025)
 Figure 45. Latin America Recombinant Human Serum Albumin Sales Market Share by Type (2020-2025)
 Figure 46. Latin America Recombinant Human Serum Albumin Sales Market Share by Application (2020-2025)
 Figure 47. Middle East and Africa Recombinant Human Serum Albumin Revenue Growth Rate 2020-2031 (US$ Million)
 Figure 48. Middle East and Africa Recombinant Human Serum Albumin Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Recombinant Human Serum Albumin Revenue Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Recombinant Human Serum Albumin Sales Market Share by Type (2020-2025)
 Figure 51. Middle East and Africa Recombinant Human Serum Albumin Sales Market Share by Application (2020-2025)
 Figure 52. Recombinant Human Serum Albumin Supply Chain (Upstream and Downstream Market)
 Figure 53. Global Production Market Share of Recombinant Human Serum Albumin Raw Materials by Region in 2024
 Figure 54. Recombinant Human Serum Albumin Distribution Channels
 Figure 55. Global Recombinant Human Serum Albumin Percentage 2020-2031: Indirect Sales VS Direct Sales
 Figure 56. Global Recombinant Human Serum Albumin Percentage 2020-2031: Online Sales VS Offline Sales
 Figure 57. Bottom-up and Top-down Approaches for This Report
 Figure 58. Data Triangulation
 Figure 59. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$5900

This license allows only one user to access the PDF.
Electronic (PDF)

$8850

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$11800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String